Nuveen Asset Management LLC Has $2.90 Million Holdings in Ardent Health Partners, LLC (NYSE:ARDT)

Nuveen Asset Management LLC grew its position in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 220.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 169,475 shares of the company's stock after purchasing an additional 116,610 shares during the period. Nuveen Asset Management LLC owned about 0.12% of Ardent Health Partners worth $2,895,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in ARDT. US Bancorp DE acquired a new position in Ardent Health Partners during the 4th quarter valued at about $31,000. Ventas Inc. bought a new stake in Ardent Health Partners during the 4th quarter worth approximately $159,570,000. Barclays PLC increased its stake in Ardent Health Partners by 24.7% during the 4th quarter. Barclays PLC now owns 26,177 shares of the company's stock worth $447,000 after purchasing an additional 5,185 shares in the last quarter. Prudential Financial Inc. bought a new stake in Ardent Health Partners during the 4th quarter worth approximately $481,000. Finally, Rhumbline Advisers boosted its position in Ardent Health Partners by 23.9% during the 4th quarter. Rhumbline Advisers now owns 16,913 shares of the company's stock worth $289,000 after acquiring an additional 3,266 shares during the last quarter.

Ardent Health Partners Trading Down 0.1%

Shares of NYSE:ARDT traded down $0.02 during midday trading on Wednesday, hitting $14.55. 153,403 shares of the stock were exchanged, compared to its average volume of 387,294. The stock has a market capitalization of $2.08 billion and a price-to-earnings ratio of 8.93. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The business's 50-day moving average price is $13.41 and its 200 day moving average price is $14.63. Ardent Health Partners, LLC has a 12 month low of $11.31 and a 12 month high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.08. The firm had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.50 billion. Analysts predict that Ardent Health Partners, LLC will post 1.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ARDT. Mizuho reduced their price target on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Stephens reaffirmed an "overweight" rating and set a $21.00 price target on shares of Ardent Health Partners in a report on Tuesday, May 20th. Guggenheim lifted their target price on Ardent Health Partners from $16.00 to $18.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $21.00 price target on shares of Ardent Health Partners in a research report on Thursday, May 15th. Two analysts have rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $20.67.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.